Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 865-876 of 10,612

Drug study icon

RecruitingNCT06668571

Intravenous Ketamine for Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Depression

Behavioral study icon

RecruitingNCT05239780

Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 18 Years to 80 Years

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai
Condition: Depression

Drug study icon

RecruitingNCT06526208

Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Southwest Autism Research & Resource Center
Condition: Anxiety

Behavioral study icon

RecruitingNCT05700201

Investigating Cardiac Health of Adults With Trauma

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: Nova Southeastern University
Condition: PTSD

Other study type icon

RecruitingNCT05927974

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDiagnostic TestOver 18 Years

Countries: United States
Sponsor: University of Alabama at Birmingham
Condition: Depression

Behavioral study icon

RecruitingNCT07217652

Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, ADHDBehavioralFrom 18 Years to 35 Years

Countries: United States
Sponsor: Kai Hwang
Condition: Schizophrenia, ADHD

Drug study icon

RecruitingNCT05649059

Investigating the Effects of Cannabidiol on Social Anxiety Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts Institute of Technology
Condition: Anxiety

Behavioral study icon

RecruitingNCT05957159

Investigating the Mu:Kappa Opioid Receptor Imbalance in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 21 Years to 70 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Device study icon

RecruitingNCT05996900

Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 18 Years to 65 Years

Countries: United States
Sponsor: Stanford University
Condition: Depression

Drug study icon

RecruitingNCT06511908

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression

Drug study icon

RecruitingNCT06512194

Investigation to Understand and Optimize Psilocybin

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Charles Raison
Condition: Depression

Drug study icon

RecruitingNCT07064564

iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Akyso Therapeutics, LLC
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.